Cited 14 time in
Reversible opacification of hydrophobic acrylic intraocular lens- two cases report
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Dong Ju | - |
| dc.contributor.author | Chuck, Roy S. | - |
| dc.contributor.author | Lee, Jimmy K. | - |
| dc.contributor.author | Park, Choul Yong | - |
| dc.date.accessioned | 2024-08-08T06:30:59Z | - |
| dc.date.available | 2024-08-08T06:30:59Z | - |
| dc.date.issued | 2017-06-30 | - |
| dc.identifier.issn | 1471-2415 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/19050 | - |
| dc.description.abstract | Background: The opacification of the intraocular lens (IOL) can cause significant visual deterioration. It is known that opacity of hydrophobic acrylic IOLs is rare. We report 2 cases of reversible optic opacification of hydrophobic acrylic intraocular lenses (Tecnis ZCB00, Abbott), observed within 2 months after uneventful cataract surgery. Case presentation: Case 1: Uneventful cataract surgery was performed on the left eye of an 86-year-old diabetic man with chronic open-angle glaucoma. A hydrophobic acrylic intraocular lens (IOL; Tecnis ZCB00, Abbott, Lake Bluff, IL) was implanted in the bag. Eye drops containing 0.5% levofloxacin and 1.0% prednisolone were used after surgery along with topical anti-glaucoma medications. At 7 weeks postoperative, cloudy, concentric IOL opacification developed, accompanied by decreased visual acuity and increased intraocular pressure. However, the opacification completely disappeared after 9 weeks. Case 2: Uneventful cataract surgery was performed on the left eye of a 72-year-old woman. A hydrophobic acrylic IOL (Tecnis ZCB00) was implanted in the bag. At 2 weeks postoperative, cloudy, concentric IOL opacification developed, accompanied by ocular discomfort. After 4 weeks, opacification and discomfort completely disappeared. Conclusions: We observed two cases of completely reversible opacification of hydrophobic acrylic IOLs. The exact nature of the transient opacity remains unclear, but an inflammatory origin cannot be completely ruled out. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | BIOMED CENTRAL LTD | - |
| dc.title | Reversible opacification of hydrophobic acrylic intraocular lens- two cases report | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1186/s12886-017-0509-0 | - |
| dc.identifier.scopusid | 2-s2.0-85021653149 | - |
| dc.identifier.wosid | 000405029700001 | - |
| dc.identifier.bibliographicCitation | BMC OPHTHALMOLOGY, v.17, no.1 | - |
| dc.citation.title | BMC OPHTHALMOLOGY | - |
| dc.citation.volume | 17 | - |
| dc.citation.number | 1 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Ophthalmology | - |
| dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
| dc.subject.keywordPlus | ANTERIOR SEGMENT SYNDROME | - |
| dc.subject.keywordPlus | SURFACE LIGHT-SCATTERING | - |
| dc.subject.keywordPlus | LATE POSTOPERATIVE OPACIFICATION | - |
| dc.subject.keywordPlus | POLY(METHYL METHACRYLATE) | - |
| dc.subject.keywordPlus | VISUAL FUNCTION | - |
| dc.subject.keywordPlus | GLISTENINGS | - |
| dc.subject.keywordPlus | ACRYSOF | - |
| dc.subject.keywordPlus | CALCIUM | - |
| dc.subject.keywordAuthor | Cataract | - |
| dc.subject.keywordAuthor | Intraocular lens | - |
| dc.subject.keywordAuthor | Hydrophobic | - |
| dc.subject.keywordAuthor | Acrylic | - |
| dc.subject.keywordAuthor | Reversible | - |
| dc.subject.keywordAuthor | TASS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
